The U.S. Food and Drug Administration (FDA) has recently given its approval for a groundbreaking technique that uses sound waves to combat liver tumors. Known as histotripsy, this non-invasive method offers a promising alternative to traditional cancer treatments like surgery, chemotherapy, and radiation.
Developed at the University of Michigan and championed by HistoSonics, this innovative approach has the potential to revolutionize cancer care, providing patients with a safer and more effective option.
Read more: Tumor-destroying sound waves receive FDA approval for liver treatment in humans
